Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -6.11M | -6.17M | -6.93M | -7.25M |
| Total Depreciation and Amortization | 163.20K | 184.10K | 186.00K | 187.80K | 219.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 351.30K | 419.50K | 522.70K | 945.90K | 944.60K |
| Change in Net Operating Assets | -400.50K | 504.30K | 571.00K | 403.40K | -258.90K |
| Cash from Operations | -5.72M | -5.00M | -4.89M | -5.39M | -6.34M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -29.50K | -29.50K | -29.50K | -29.50K |
| Issuance of Common Stock | 7.64M | 1.04M | 729.40K | 1.21M | 1.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 9.88M | 1.54M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -597.30K | -194.30K | -107.80K | -147.70K | -207.80K |
| Cash from Financing | 16.92M | 2.36M | 592.00K | 1.04M | 1.67M |
| Foreign Exchange rate Adjustments | -98.00K | -61.30K | -25.90K | -61.00K | -2.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.10M | -2.70M | -4.32M | -4.42M | -4.67M |